This study evaluated the lung microbiome in adult patients undergoing lung resection for suspected or confirmed malignancy. The authors enrolled 86 patients and, under sterile conditions after surgical resection, collected two sample types from each specimen: a 1 cm cubic piece of non-cancerous lung parenchyma and a swab from the specimen's bronchus. Samples were designated to compare airway-derived versus tissue-derived microbial profiles and to determine variability across anatomic location and patient characteristics.
The cohort and sampling strategy were designed to limit intra-procedural contamination by obtaining specimens after resection. The focus on non-cancerous parenchyma aimed to characterize the background lung microbiome in the perioperative setting for patients with pulmonary neoplasia.
All microbiome profiling used 16S rRNA gene amplicon sequencing targeting the V4 region on an Illumina sequencing platform. The study applied an established bioinformatics pipeline for taxonomic identification from sequence data. The manuscript reports sequencing-based taxonomic assignment and diversity analyses as the core laboratory endpoints.
Clinical and demographic baseline data were collected and compared to microbiome composition metrics to evaluate associations between patient-level factors and microbial community structure.
The principal analytic focus was microbial community composition (beta diversity). Initial comparisons demonstrated a significant difference in beta diversity between the two sampling methods — parenchymal biopsy versus airway swab. Because of that global distinction, the authors performed further analyses within each sample type rather than pooling airway and tissue samples.
Within-sample-type analyses identified additional structured variation. The study reports that microbial composition differed significantly by lobe of the lung, indicating that anatomic location within the lung is associated with distinct microbial communities. These findings emphasize that sampling strategy and intra-pulmonary location materially affect observed microbiome profiles.
Beyond sampling method and lobe-specific differences, the investigators examined associations between patient characteristics and microbial composition. They report significant differences in beta diversity related to age and specific comorbidities, including chronic obstructive pulmonary disease (COPD) and atrial fibrillation. The paper does not report numerical effect sizes, specific taxa driving these associations, or results of longitudinal sampling; those details are not provided in the abstracted source text.
Because the airway swab and parenchymal biopsy produced distinct community profiles, the authors interpret their findings to mean that sampling approach is a key determinant of observed lung microbiome structure and should be considered when designing future studies or comparing results across studies.
Sequencing data generated for this study are accessible at NCBI BioProject ID PRJNA1428797 under the project title "Pulmonary Oncogenesis Microbiome Following Surgery."
The research received institutional review board approval from Loyola University Chicago (LU#215744; 3/21/22). The authors state that all necessary patient consent and regulatory approvals were obtained and that they have followed appropriate reporting guidelines. No competing interests were declared.
Funding support is noted from the Cardiovascular Research Institute at the Stritch School of Medicine, Loyola University Chicago, through the Patrick Scanlon Collaborative Grant Award.
In this surgical cohort, the lung harbors a diverse microbiome whose measured composition depends on the sampling method (airway swab versus parenchymal biopsy) and anatomic location (lung lobe). Patient factors such as age and comorbidities including COPD and atrial fibrillation were associated with differences in beta diversity.
The authors present their sterile post-resection sampling framework and sequencing workflow as a model to reduce contamination and sampling error that have complicated prior lung microbiome studies. They suggest that careful attention to sampling type and anatomic site is important for future work aiming to relate lung microbial communities to disease processes, healing, or clinical outcomes.
Limitations and specific taxonomic or effect-size details are not reported in the abstracted portion of the source; the manuscript is a preprint and has not undergone peer review, so findings should be interpreted accordingly.